KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Change in Receivables (2018 - 2026)

Moderna (MRNA) has disclosed Change in Receivables for 9 consecutive years, with -$114.0 million as the latest value for Q1 2026.

  • For Q1 2026, Change in Receivables rose 59.29% year-over-year to -$114.0 million; the TTM value through Mar 2026 reached $10.0 million, up 116.95%, while the annual FY2025 figure was -$156.0 million, 70.79% up from the prior year.
  • Change in Receivables hit -$114.0 million in Q1 2026 for Moderna, up from -$859.0 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $1.6 billion in Q3 2023 and bottomed at -$1.3 billion in Q4 2022.
  • Average Change in Receivables over 5 years is -$181.6 million, with a median of -$272.0 million recorded in 2023.
  • On a YoY basis, Change in Receivables climbed as much as 40750.0% in 2023 and fell as far as 27100.0% in 2023.
  • Moderna's Change in Receivables stood at -$1.3 billion in 2022, then rose by 25.65% to -$974.0 million in 2023, then fell by 23.82% to -$1.2 billion in 2024, then grew by 28.77% to -$859.0 million in 2025, then skyrocketed by 86.73% to -$114.0 million in 2026.
  • According to Business Quant data, Change in Receivables over the past three periods came in at -$114.0 million, -$859.0 million, and $1.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.